DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel.
The promotion will target orthopedic surgeons, reconstruction, spine sports medicine and trauma professionals. The two companies have already begun to promote the drug, marketing it as a non-habit forming pain medication, working at the site of surgery.
“There are millions of orthopedic procedures performed in the US market today where we can improve patient care and the surgical experience by offering a long acting, intra-operatively delivered local anesthetic solution,” Juan-Jose Gonzalez, president of DePuy Synthes, said. “As part of our focused approach to help bring value at every point of care, we are thrilled to be able to further our offerings through partnering with Pacira, and together provide a differentiated solution for our customers to help improve patient outcomes.”
Exparel pain reliever receives major endorsement
Alerts Sign-up